API Sterilization With Curia

Several methods are available to sterilize active pharmaceutical ingredients (APIs), including terminal sterilization techniques such as dry heat, moist heat, and radiation. However, these approaches are not always suitable, particularly when the molecule’s stability or impurity profile may be compromised during terminal treatment.

In these cases, Curia offers aseptic processing capabilities designed to maintain product integrity while achieving the required sterile grade for the formulated API. By applying the principles of Quality Risk Management (QRM), Curia carefully designs and controls its facilities, equipment, systems, and operating procedures to support sterile manufacturing. This integrated approach helps ensure that microbial, particulate, and endotoxin contamination are effectively prevented in the final product.